🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
The study will have 2 independent parts: Part 1 of the study is intended t...
Status
Completed
Location
Research Site
Start Date
2021-07-29
Trial ID
NCT04991571
The study is designed to test whether or not the rate and extent of absorpt...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-09
Trial ID
NCT01677039
The purpose of this study is to assess the rate and extent of absorption of...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-02-06
Trial ID
NCT03010059
Treatments Being Tested
The purpose of the study is to compare the pharmacokinetic (PK) profiles an...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02356913
Treatments Being Tested
This is a Phase 1, single-center, randomized, double-blind, active-controll...
Status
Not Yet Recruiting
Location
Veeda Clinical Research Ltd
Start Date
2026-04
Trial ID
NCT07502144
Treatments Being Tested
* To evaluate the pharmacokinetic (PK) profiles of MIN-l0l following admini...
Status
Completed
Location
Biokinetic Europe
Start Date
2016-11-30
Trial ID
NCT03038646
Treatments Being Tested
The purpose of this study is to estimate the relative bioavailability of ni...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-08-31
Trial ID
NCT05525910